Lv31
220 积分 2023-08-19 加入
Research progress of STAT3-based dual inhibitors for cancer therapy
2小时前
已完结
Decoy-PROTAC for specific degradation of “Undruggable” STAT3 transcription factor
8天前
已完结
The Nonclinical Safety Assessment of a Novel Anti-CEACAM5 Antibody Exatecan Conjugate Predicts a Low Risk for Interstitial Lung Disease (ILD) in Patients—The Putative Mechanism Behind ILD
13天前
已完结
ByeTAC: Bypassing E-Ligase-Targeting Chimeras for Direct Proteasome Degradation
15天前
已完结
MYC in cancer: from undruggable target to clinical trials
1个月前
已完结
Targeting cancer with small molecule pan-KRAS degraders
1个月前
已完结
Applications of Bioisosteres in the Design of Biologically Active Compounds
1个月前
已完结
Discovery of Benzoazepinequinoline (BAQ) Derivatives as Novel, Potent, Orally Bioavailable Respiratory Syncytial Virus Fusion Inhibitors
1个月前
已完结
Development of bispecific antibodies in China: overview and prospects
1个月前
已完结
The “three body solution”: Structural insights into molecular glues
2个月前
已关闭
皖公网安备34019202002308
